Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Ganesh Raghu, Harold R. Collard, Jim Egan et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 7.1K citations · Full text

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Paul W. Noble, Carlo Albera, Williamson Z. Bradford et al. · The Lancet · 2011 · 2.1K citations

Antifibrotic Therapy, Idiopathic Pulmonary Fibrosis, Pharmacology +6

Prednisone, Azathioprine, and <i>N</i> -Acetylcysteine for Pulmonary Fibrosis

New England Journal of Medicine · 2012 · 1.5K citations · Full text

Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Arata Azuma, Toshihiro Nukiwa, Eiyasu Tsuboi et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 944 citations

Acute Lung Injury, Fatal Disorder, Antifibrotic Therapy +16

Pirfenidone in idiopathic pulmonary fibrosis

H. Taniguchi, Masahito Ebina, Yasuhiro Kondoh et al. · European Respiratory Journal · 2009 · 933 citations · Full text